Tw o h u n d re d seventy-five consecutive patients treated with b o n e m a rro w tran sp lan ta tio n (BMT) d u rin g a 9 -y e a r interval w e re a n a lyze d for the incidence a n d etiology of n o so c o m ia l p n e u m o n ia . C a s e s included a d ults w h o a cq u ire d p n e u m o n ia d u rin g the first h o sp i talization p eriod w ithin 1 0 0 d a y s of the transplant. Fifty-five (2 0 % ) of the 2 7 5 patients d e v e lo p e d n o so c o m ial p n e u m o n ia , a n d the crude m ortality d u rin g the hosp italization p eriod w a s 7 4 .5 % . A n etiology w a s estab lishe d in 6 7 . 3 % (37 of 55) of e p isodes. Thirty-six percent (2 0 of 55) of the cases w e re ca u se d by A sp e rg il lus species, either a s the so le a g e n t (15 patients) o r in a sso cia tio n with others. The crude m ortality for p a tients w ith A sp e rgillu s p n e u m o n ia w a s 9 5 % . E lim in a tion of 9 0 % of A sp ergillu s ca se s in o u r unit w o u ld h a ve the effect of re d ucing the o ve ra ll attack rate of n o so c o m ial p n e u m o n ia to 1 3 .4 % a n d the a sso cia te d crude m ortality to 4 3 .4 % . P N E U M O N IA rem ains a significant cause of m orbidity and m ortality in bone m arrow tran sp lan tatio n (B M T ) patients. R ecen t studies have re p o rte d rates of p neum onia ranging from 35 to 43 p e r 100 tran sp lan t patien ts and crude m o rtal ity figures varying from 58% to 84% .10 In general, cytom egalovirus (C M V ) has b een found to be the m ost fre q u en t etiologic agent, but m ost of the studies have restricted th e ir analyses to the in te r stitial p neum onitis syndrom e. T he la tte r is ch arac terized by th e developm ent of dyspnea, n onproduc tive cough, hypoxem ia, and interstitial infiltrates on chest radiographs, w hich occur in the absence o f d ocum ented bacterial o r fungal infection.24 H ow ever, in recen t years, ce rtain fungal infections have b ee n found to b e m ajor causes o f pneum onia and fatality following BM T.5'6 F u rth erm o re, re sults of studies o f B M T-associated pneum onia could vary not only according to study design factors such as th e criteria used for case definition, b u t also by th e diagnostic approaches, age, p ri mary diagnoses of th e patients, the hum an leuko cyte antigen m atching betw een do n o r and recipi ent, and the length of th e follow-up.
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In o rd er to achieve an accurate perspective of B M T-associated pneum onias, it is desirable to approach th e problem from an u n restricted p e r spective. In this rep o rt, we define th e incidence and etiology o f nosocom ial p neum onia occurring during th e first hospitalization p eriod for 275 consecutive B M T patients. S trict case definitions w ere used, and all patien ts w ere identified by prospective surveillance. All w ere adults w ho w ere tre a te d at the U niversity of Iowa H ospitals and Clinics (U IH C ) A d u lt Bone M arrow T ran sp lan t U nit from Jan u ary 1, 1980 to D ecem b er 31, 1988 .
MATERIALS AND METHODS
The U IH C is a 900-bed teaching hospital providing tertiary care for the state of Iowa and surrounding areas. In January 1980, a bone marrow transplant program was begun, and 373 procedures have been perform ed through Decem ber 1988 (98 on pediatric patients and 275 on patients 16 years of age or older). A prospective infection control surveillance program has been active at U IH C since 1976. R ecent validation studies using standard m ethods7 showed that the sensitivity and specificity of hospital-wide reports were 81% and 97%, respectively.8 Since May 1980 the data have been stored in an on-line com puter system.
Case Definitions
An infection was defined as nosocomial if it was neither present nor incubating at the time of the admission and did not become m anifest until 72 hours following admission. An infection present at admission was classified as nosocomial
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only if it was directly related to a previous admission and occurred within 10 days of discharge.
Nosocomial pneum onia was defined in a patient who had a chest radiographic examination with a new or progressive infiltrate and at least one of the following criteria: (1) new onset of rales on physical examination; (2) new onset of sputum production or change in character of sputum; (3) isolation of a pathogenic agent from bronchoalveolar lavage (BAL) ( ^ 100,000 colonies per milliliter m andatory for bacteria) or pulmonary tissue; (4) recovery of Histoplasma, Cryptococcus, Aspergillus, or Mucor species, Pneumocystis carinii, Nocardia or Actinomyces species, Mycobacterium species, or Legionella species from sputum, BAL or tissue biopsy; (5) recovery of a pathogenic agent from a blood culture that was the same species as that recovered from the sputum culture; (6) isolation of a virus or detection of viral antigens in respiratory secretions (except for CMV, herpes simplex virus (HSV), or E pstein-Barr virus; and (7) histo pathologic evidence of pneum onia (m andatory for Candida species).
T he diagnosis of CMV pneum onia required the isolation of CMV from BAL fluid or pulmonary tissue biopsy. We then attem pted to stratify the infections into those that were primary and those that were secondary. Primary CMV infection was defined in patients who were seronegative before the transplant and dem onstrated a fourfold or greater increase in immunoglobulin G (IgG)-and IgMspecific CMV antibodies and/or in whom a positive isolation of the virus from any site in the period posttransplant was obtained. For the definition of secondary infection the same criteria were used for patients who were seropositive before the transplant.
Almost all patients in this series received large amounts of blood products, including intravenous IgG in some cases. Since this could represent a source of passively acquired CMV antibodies, the patients who presented an increase of CMV-specific IgG antibodies without a concurrent IgMpositive titer or CMV isolation were considered as having an indeterm inant CM V infection status.
Exclusion Criteria
For the purpose of this study, we excluded any patient with one of the following diagnoses: acute respiratory distress syndrome (ARD S), atelectasis, neoplasic pulmo nary infiltration, pulmonary hem orrhage, pulmonary em bo lus with infarction, or fluid overload.
Case Finding
Cases were identified by screening the infection control surveillance data and identifying all patients who were 18 years of age or older who were subjected to a BMT and acquired nosocomial pneum onia during the first hospitaliza tion period within 100 days of the transplant. W hen these patients were identified, additional clinical criteria were applied to m eet our case definition, which is m ore rigorous than that used in routine epidemiologic surveillance.
Patient Supportive Care
D etails of the transplant procedure at this institution have been reported elsewhere.' All patients were housed in single rooms ventilated centrally with high-efficiency partic ulate air (HEPA )-filtered air at four exchanges per hour. During the time of neutropenia, patients were m aintained in simple reverse isolation: individuals entering the room wore a clean hospital gown and observed thorough hand washing practices. Patients were allowed to leave their rooms only for diagnostic or therapeutic procedures and were required to w ear surgical masks and clean gowns.
On admission to the transplant unit an indwelling double lumen intravenous catheter was placed surgically. Trim ethoprim-sulfamethoxazole in the form of a double strength tablet was given orally twice daily from day -8 through day -1 and resum ed from day 28 (or when the neutrophil count was > 500/mm') through day 100. Acyclo vir was given three times daily intravenously from day +1 at 500 m g/nr until the time of the engraftm ent and then switched to 400 mg orally three times daily until day 100. Daily showers are required with a chlorhexidine-containing soap.
Blood products were transfused for a hemoglobin less than 10 g/dL or a platelet count less than 20,000/mm1. Since the beginning of the bone marrow transplant program, patients whose serologic tests for CMV were negative were given CMV-negative blood products throughout the period of cytopenia.
Febrile, neutropenic patients were clinically evaluated, cultured at all im portant sites and immediately staricd oil broad-spectrum antibiotics. O ver the course of the study, the latter included vancomycin, tobramycin, and a beta-lactam antibiotic. If the patient rem ained febrile after 3 days, am photericin B was begun and quickly escalated to a daily dose of 0.6 mg/kg. Broad-spectrum antibiotic coverage was continued until the neutrophils were greater than 500 cells per cubic m illimeter for two consecutive days and the patient became afebrile.
Surveillance Cultures
Surveillance cultures for bacteria and fungi were ob tained weekly from the skin, nose, throat, urine, and anus since 1985 for all BM T patients. In addition, weekly samples of sera were tested by latex bead agglutination method (Cand-Tec; Ramco, Houston, TX) for Candida antigen.
Environm ental air cultures for fungi were introduced in Septem ber 1987. Air samples were perform ed using a surface air system (Pool Bioanalysis, Italy) portable air sam pler (time of sampling of 1 m inute, airflow of 180 L/min) and were obtained from the BMT unit and from various sites outside the unit, including the Radiology unit, R adia tion T herapy unit, and some outdoor areas.
RESULTS

Study Population and Incidence o f Nosocom ial Pneum onia
D u rin g th e 9-year study p erio d , 76 cases of nosocom ial p n eu m o n ia w ere identified by the infection control surveillance system. O f th e 76 cases, 72 could be review ed (four ch arts w ere not available). A lthough seventeen o f th e cases m et
surveillance criteria, they did not m eet all o f the clinical criteria im posed for this study and w ere excluded for th e following reasons: two acquired nosocom ial pneum onia during th e first hospitaliza tion period but after 100 days o f the BM T, four did not fulfill the clinical criteria o f th e study, and 11 w ere judged to have o th e r diagnoses (six adult respiratory distress syndrom e, th ree fluid over load, one atelectasis, and th e o th e r leukem ic infiltrate of th e lungs). T hus, 55 cases o f p n eu m o nia, occurring in 53 patients, w ere included in th e p resent series (tw o p atien ts had two distinct ep i sodes). This constituted an incidence of 20% (55 of 275) during the study period. T he inclusion of the four cases for w hich charts w ere not available would have increased the incidence to 21.4% . T hirteen o f the 21 patien ts excluded from the study for any reason (62% ) died during th e hospi talization period im m ediately after th e BM T.
Demographic Features
Fifty-six p erc en t (31 of 55) o f the p atien ts w ere male, and the m ean age was 31 ( ± 11) years. T he most frequent prim ary diagnosis o f the pneum onia patients was chronic myeloid leukem ia (20 of 55, 36.4%), followed by acute leukem ia and lym phom a (16 patien ts each). A n o th er two p atien ts had aplastic anem ia, and th e o th e r had ad en o car cinom a o f the breast. Forty o f th e 55 patien ts (72.7% ) received allogeneic transplants. O f those, 21 (38.2% ) had an u nrelated donor, and 19 (34.5% ) received th e b one m arrow from a sibling. F ou rteen transplants w ere autologous, and the rem aining patient was syngeneic. Forty-eight percen t (25 of 52) o f the patien ts w ere serologically positive for CM V before the tran splantation. In one case this inform ation was not available.
Interval to Infection and Etiology
T he m edian interval betw een B M T and identifi cation of th e pneum onia w as 21 days, w ith a m ean of 28 ( ± 25) days and a range from 2 to 85 days (Fig 1) . Bronchoscopy with cytologic observation and viral culture of specim ens obtain ed by BA L was p erform ed in 69.1% o f the patients, open lung biopsy o r transthoracic needle aspiration in 12.7% (seven of 55), and autopsy studies in 14 of th e 41 patients (34.2% ) w ho died.
An etiology was established in 37 of the 55 episodes (67% ) (T able 1). F ifteen o f the 18 patients for w hom no etiology was established w e e k s a f t e r t r a n s p la n t a t io n Fig 2) . T he m onthly distribution of Aspergillus pneu m o n ia indi cates th a t th e re w as a strong late au tu m n p eak for this infection th a t was n ot observed in th e nonAspergillus cases (Fig 3) . T h e m ed ian interval betw een th e BM T and th e pneu m o n ia in this subset of p atien ts w as 14 days, w ith a m ean o f 19 ( ± 15) days an d a range from 2 to 65 days. E ight of th e 20 isolates w ere identified as Aspergillus flavus, five as Aspergillus fumigatus, an d on e as Aspergillus niger. A n o th er two p atien ts had b o th A flavus and A fum igatus recovered from th e cultures, and in th e rem aining fo u r p atients, the species of the Aspergillus was n ot d eterm in ed . In th re e o f those Table 1 patien ts th e diagnosis of Aspergillus was b ased on histopathologic findings at autopsy2 o r skin biopsy.1 CM V, the second m ost fre q u en t etiologic agent in the p resen t series, caused pneum onia in seven of the 55 patien ts (12.7% ). O ne of the patien ts had both CM V and respiratory syncytial virus (R SV ) identified in respiratory secretion and lung tissue sam ples. T h ree of seven cases (42.8% ) w ere classi fied as prim ary CM V infections and th e rem aining four as secondary. T he interval betw een th e BM T and the onset of th e p neum onia ranged from 44 to 85 days, w ith a m edian o f 55 and a m ean o f 58 days. Two patien ts p resen ted w ith serologic evidence of CM V infection w ithout pneum onia. A dditionally, 10 o th e r patien ts w ere considered as having an indeterm inant CM V infection status, since they prese n ted an increase o f IgG-specific CM V an ti bodies w ithout a concu rren t IgM positivity or CM V isolation. cases o f p neum onia w ith a m ean o f 15.6 ( ± 8.6) sam ples p e r p atien t, a m edian of 13.5, and a range from 4 to 41. T he m ean nu m b er of cultures p er p atient was 3.3 ( ± 2.0) from the skin, 3.2 ( ± 2.0) from the stool, 2.2 ( ± 1.4) from th e urine, 3.3 ( ± 1.9) from th e nose, and 3.6 ( ± 2.1) from the oropharynx. F ifteen o f th e 20 p atien ts with pulm o nary aspergillosis had surveillance cultures p e r form ed at regular intervals before th e diagnosis of pneum onia: no Aspergillus species was isolated from a to tal of 209 cultures from different sites, including 93 from th e nose and oropharynx. O n the o th e r hand, none of th e 199 nasal and/or oropharyngeal surveillance cultures of cases w ith o ut th e diagnosis o f Aspergillus p neum onia was positive for this agent. In one p atient, a culture of a swab taken from th e skin grew Aspergillus spe cies. N o o th e r etiologic agent w as isolated from this p atient. Aspergillus was not considered the cause of th e pneum onia b ecause this agent was n ot d em onstrated in sputum , BAL, or tissue biopsy.
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T he surveillance cultures also did not co rrelate w ith th e etiologic agents isolated from th e o th e r cases o f pneum onia. T he only exception might be C albicans, w hich was isolated from surveillance cultures from two of th ree cases o f Candida pneum onia (from stools in one p atien t and from the oropharynx in th e oth er). H ow ever, positive surveillance cultures for C albicans w ere also found in 41% (16 o f 39) o f the p atien ts w ithout C albicans pneum onia. W ithin this group, the p ro p o r tion o f p atien ts w ith positive surveillance cultures for C albicans (any site, any tim e before the pneum onia) w as 36% (eight o f 22) in patients from whom an etiologic diagnosis for the pn eu m o nia was established, and 47% (eight o f 17) in the group w ith unknow n etiology.
Eighty-seven o f 257 (33.8% ) environm ental air 
DISCUSSION
T he 20% attack rate for p n eu m o n ia in BM T p atien ts observed in the p resen t study is low er th an th e 35% to 43% rates rep o rted in recen t series.15 O u r prospective case-finding m eth o d and th e exclusion o f 17 cases th a t did not m eet the m ore restrictive criteria used in th e p rese n t study, are b o th factors th a t may have co n trib u ted to this figure. W e also have restricted o u r cases to p a tients w ho p rese n ted with pneu m o n ia during the first hospitalization period and w ithin 100 days of th e BM T. T his is substantially different from the period o f study o f o th e r series.14 C M V is stated to be the m ost fre q u en t etiologic agent of p n eum onitis after BM T, w ith an attack rate ranging from 36 to 61 p e r 100 p atien ts.2'5 This co n trasts w ith th e rate of 12.7 p er 100 found in the p rese n t series. Bronchoscopy w ith cytologic o b ser vation and viral cu ltu re of specim ens o b tain ed by BAL, a highly sensitive test for th e d etectio n of CM V infection of the lungs,1011 was p erfo rm ed in 69% o f th e p atien ts in th e p resen t study. O f th e 17 p atien ts w ithout BAL, four had specim ens subm it ted for lung biopsy and in six d eaths, autopsy studies w ere perfo rm ed . T hus, th e low rate of CM V infections in th e p resen t study is not a result o f in ad eq u ate diagnostic approach. T h e fact th at 32% (88 o f 275) of th e p atien ts in o u r study w ere trea ted w ith autologous tran sp lan tatio n could have co n trib u ted to a low er incidence of CM V p n e u m onitis in this series.12 H ow ever, th e m ost im por ta n t factor is possibly rela ted to th e length of observation o f the patien ts, since 34.5% of the p atien ts died o r w ere discharged w ithin 6 w eeks of th e BM T, and 45.4% died o r w ere discharged w ithin 8 weeks. T he m ean interval betw een the BM T and CM V pneu m o n ia in th e p resen t series was 58 days. In a study o f 545 recipients of allogeneic BM T, the m edian o nset of CM V p n e u m onia w as 62 days after tran sp lan t.13 F u rth e r m ore, th e use o f C M V -negative blood products in all p atien ts w hose serologic tests for CM V w ere negative, and the use (since 1987) of intravenous IgG in th e previously seropositive patients, may also have contributed to a low er incidence of CM V pneum onia.
B M T recipients have been found to have a 10-fold g rea ter incidence o f nosocom ial Aspergillus infection th an o th e r im m unocom prom ised p atien t p o p u latio n s,14 and this organism has em erged as a m a jo r ca u se o f m o rta lity in the tra n s p la n t p opulation.6,7 H ost factors, such as corticosteroid therapy,15 prolonged n eu tro p e n ia,16 chronic myelog enous leukem ia, o r aplastic anem ia as prim ary diagnoses befo re allogeneic B M T 17 have been shown to increase the risk o f invasive aspergillosis in im m unocom prom ised patients. Sixteen o f the 20 (80% ) p atien ts w ith aspergillosis w ere receiving steroids at th e tim e o f th e pneum onia, 16 (80% ) w ere n eutropenic, and eight (40% ) had a prim ary diagnosis o f chronic m yelogenous leukem ia. In addition, 50% (10 o f 20) o f th e p atien ts with Aspergillus w ere receiving am photericin B for 7 days o r m ore w hen th e pneu m o n ia was diagnosed.
O u tbreaks of nosocom ial aspergillosis have been traced to heavy contam ination o f th e hospital air associated w ith dust and d irt raised during hospi tal renovation and constru ctio n .18"24 A side from an unexplained peak in 1985 (incidence rate o f 20.8% ) th e annual incidence of pulm onary aspergillosis has b een stable at 5% to 10%. T he overall attack rate of 7.3% (20 o f 275) observed in this study is com parable to attack rates ranging from 4% to 8.4% found in o th e r series. 7-25-26 In ad e q u ate filtra tion of outside air by th e air-handling system is the m ost obvious source o f Aspergillus spores in the h osp ital,19,27 and significant reductions of th e inci dence o f nosocom ial aspergillosis have b een shown by im proving th e quality o f th e air in BM T u n its.15111 T h e associated finding o f positive cul tu res for fungi in 11.4% o f th e air sam ples o b tain ed from the BM T unit indicates th a t th e four exchanges p e r h o u r of centrally H E P A -filtered air th a t has been ro u tin e in o u r B M T unit does not elim inate th e risk of Aspergillus pneum onia. F u r th erm o re, th e higher rate of positive environm en tal cu ltu res of air sam ples o b tain ed in th e BM T unit in th e S ep tem b er to N ovem ber interval su p ports a seasonal incidence. R e p o rts of seasonal variation of Aspergillus spores in o u td o o r sam ples o f air, w ith an increase of A fum igatus co n ten t from a m ean o f 0.2/m3 in late w in ter to 3.5/m3 in late fall28 co n stitu tes supportive evidence.
RSV infection, a leading cause o f hospitalacquired low er respiratory tract infection in chil d ren aged 2 years or younger,2g has recently been rep o rted as a cause of severe respiratory infections in im m unocom prom ised adults.30 T h e th ree cases of the p resen t series o ccu rred in th e w inter, in a tem poral cluster, and have been rep o rted p re viously.31 Two of these th ree p atien ts died. RSV infection should be co n sidered in BM T recipients w ith pn eu m o n ia, especially during th e w inter m onths or if p reced ed by u p p er resp irato ry -tract symptoms.
O ne of th e strategies th a t has been prop o sed to low er the m ortality rate of pneu m o n ia in im m uno com prom ised p atien ts is th e use o f aggressive diagnostic m ethods to establish an early diagnosis.32 A previous rep o rt has shown th a t weekly fungal surveillance cu ltu res o b tain ed from selected body sites from p atien ts w ith m alignancy o r those sub m itted to B M T w ere useful in predicting systemic infection for specific Candida species (Candida tropicalis).3' N egative cu ltu res for C albicans an d C tropicalis also have been shown to aid in diagnostic and th e ra p eu tic decision m aking b ecause o f a high negative predictive value.34 Forty-one p erc en t of the p atien ts w ithout Candida p n eu m o n ia had positive surveillance cu ltu res for C albicans, w hich is very sim ilar to th e 43% colonization rate found ea rlier in im m unocom prom ised p atien ts at the sam e in stitu tio n .34 O u r d a ta confirm th e low p o si tive predictive value of this finding. T h e isolation of Aspergillus species from respiratory tra c t secre tions (tran strach eal asp irate, sputum and b ro n chial w ashing), on th e o th e r han d , has b een show n to co rrelate significantly w ith invasive pulm onary aspergillosis in im m unocom prom ised p atien ts.32'34 H ow ever, th e finding o f 15 cases o f Aspergillus pneum onia in th e p resen t series o f patien ts who had persistently negative oropharyngeal and nose swab surveillance cultures suggests th a t these pro ced u res may be poorly predictive o f the devel opm ent o f a pulm onary infection by this fungus.
T he crude m ortality o f 74.5% for all pneum onia cases in th e p rese n t study, as well as th e m ortality rate of 95.0% for Aspergillus and 86% for CM V su p p o rt th e high m ortality rates o f pneu m o n ia observed in o th e r series o f p atien ts undergoing BM T.2'4'6'7 13 1428 In o u r B M T unit, elim ination of 90% of Aspergillus cases, as m ight b e expected to occur with H E P A filtration and unidirectional air flow in p a tie n ts' room s, w ould have th e effect of reducing th e overall p n eu m o n ia attack ra te from 20% to 13.4% and th e crude m ortality from 74.5% to 43.4%.
